Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus

Kleckner, 1999, Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action, Journal of Pharmacology and Experimental Therapeutics, 289, 886 McCabe, 1993, Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors, Journal of Pharmacology and Experimental Therapeutics, 264, 1248 Rho, 1994, Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acid A receptors, Annals of Neurology, 35, 229, 10.1002/ana.410350216 Subramaniam, 1995, Felbamate block of the N-methyl-D-aspartate receptor, Journal of Pharmacology and Experimental Therapeutics, 273, 878 Taylor, 1995, Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration, European Journal of Pharmacology, 289, 229, 10.1016/0922-4106(95)90099-3 Wallis, 1992, Protective effects of felbamate against hypoxia in the rat hippocampal slice, Stroke, 23, 547, 10.1161/01.STR.23.4.547 Wallis, 1995, Glycine-induced CA1 excitotoxicity in the rat hippocampal slice, Brain Research, 685, 115, 10.1016/0006-8993(95)00465-3 Wallis, 1995, Felbamate neuroprotection against CA1 traumatic neuronal injury, European Journal of Pharmacology, 294, 475, 10.1016/0014-2999(95)00568-4 Wasterlain, 1992, Felbamate reduces hypoxic-ischemic brain damage in vivo, European Journal of Pharmacology, 212, 275, 10.1016/0014-2999(92)90343-3 Wasterlain, 1993, Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia, Neurology, 43, 2303, 10.1212/WNL.43.11.2303 Wasterlain, 1996, Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia, Stroke, 27, 1236, 10.1161/01.STR.27.7.1236 The Felbamate study group in Lennox-Gastaut Syndrome, 1993, Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome), New England Journal of Medicine, 328, 29, 10.1056/NEJM199301073280105 Shields, 2000, Investigational antiepileptic drugs for the treatment of childhood seizure disorders: a review of efficacy and safety, Epilepsia, 35 (Suppl. 2), S24 Mazarati, 2000, Felbamate in experimental model of status epilepticus, Epilepsia, 41, 123, 10.1111/j.1528-1157.2000.tb00130.x Pennell, 1995, Aplastic anemia in a patient receiving felbamate for complex partial seizures, Neurology, 45, 456, 10.1212/WNL.45.3.456 Thompson, 2000, The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamate, Drug Metabolism and Disposition, 28, 434 Thompson, 1996, Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate, Chemical Research in Toxicology, 9, 1225, 10.1021/tx9601566 Dieckhaus, 2001, Role of glutathione S-transferases A1-1, M1-1 and P1-1 in the detoxification of 2-phenylpropanol, a reactive felbamate metabolite, Chemical Research in Toxicology, 14, 511, 10.1021/tx000141e Kupferberg, 2000, Fluorofelbamate: pharmacodynamic and metabolic profile of a potent anticonvulsant, Epilepsia, 41 (Suppl. 7), 214 Thompson, 1999, Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids, Epilepsia, 26, 1089 Mazarati, 1998, Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus, Brain Research, 814, 179, 10.1016/S0006-8993(98)01080-4 Mazarati, 2002, Epileptogenesis after status epilepticus: the natural history and the effects of acute treatment, Epilepsia, 10.1046/j.1528-1157.43.s.5.25.x Mazarati, 1999, N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat, Neuroscience Letters, 265, 187, 10.1016/S0304-3940(99)00238-4 DeLorenzo, 1995, Epidemiology of status epilepticus, Journal of Clinical Neurophysiology, 12, 316, 10.1097/00004691-199512040-00003 DeLorenzo, 1996, A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia, Neurology, 46, 1029, 10.1212/WNL.46.4.1029 Treiman, 1998, A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group, New England Journal of Medicine, 339, 792, 10.1056/NEJM199809173391202 Jordan, 1994, Status epilepticus. A perspective from the neuroscience intensive care unit, Neurosurgery Clinics of North America, 5, 671, 10.1016/S1042-3680(18)30494-7 Kapur, 1997, Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors, Journal of Neuroscience, 17, 7532, 10.1523/JNEUROSCI.17-19-07532.1997 Lothman, 1990, Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus, Epilepsy Research, 6, 110, 10.1016/0920-1211(90)90085-A Cavalheiro, 1991, Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures, Epilepsia, 32, 778, 10.1111/j.1528-1157.1991.tb05533.x Hellier, 1998, Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy, Epilepsy Research, 31, 73, 10.1016/S0920-1211(98)00017-5 Nissinen, 2000, A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat, Epilepsy Research, 38, 177, 10.1016/S0920-1211(99)00088-1